Adagene Inc. - ADS, each representing 1.25 ordinary shares (NQ:ADAG)
1.790
+0.030
(+1.70%)
Streaming Delayed Price
Updated: 10:53 AM EST, Dec 12, 2025
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 3,799 |
| Open | 1.760 |
| Bid (Size) | 1.780 (100) |
| Ask (Size) | 1.810 (100) |
| Prev. Close | 1.760 |
| Today's Range | 1.760 - 1.820 |
| 52wk Range | 1.300 - 3.160 |
| Shares Outstanding | N/A |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
September 09, 2025
Adagene to Participate in Two Investor Conferences in September
August 26, 2025
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
August 14, 2025
Adagene Appoints John Maraganore, Ph.D. as Executive Advisor
April 28, 2025
Frequently Asked Questions
Is Adagene Inc. - ADS, each representing 1.25 ordinary shares publicly traded?
Yes, Adagene Inc. - ADS, each representing 1.25 ordinary shares is publicly traded.
What exchange does Adagene Inc. - ADS, each representing 1.25 ordinary shares trade on?
Adagene Inc. - ADS, each representing 1.25 ordinary shares trades on the Nasdaq Stock Market
What is the ticker symbol for Adagene Inc. - ADS, each representing 1.25 ordinary shares?
The ticker symbol for Adagene Inc. - ADS, each representing 1.25 ordinary shares is ADAG on the Nasdaq Stock Market
What is the current price of Adagene Inc. - ADS, each representing 1.25 ordinary shares?
The current price of Adagene Inc. - ADS, each representing 1.25 ordinary shares is 1.790
When was Adagene Inc. - ADS, each representing 1.25 ordinary shares last traded?
The last trade of Adagene Inc. - ADS, each representing 1.25 ordinary shares was at 12/12/25 10:53 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.